Float Short %

11.38

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.08

EPS Last/This Y

0.17

EPS This/Next Y

Price

0.85

Target Price

1.57

Analyst Recom

3.6

Performance Q

-47.79

Relative Volume

0.89

Beta

1.02

Ticker: SKIN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-21	SKIN	1.305	0.17	1.78	2479
2025-03-24	SKIN	1.41	0.16	0.00	2175
2025-03-25	SKIN	1.395	0.16	0.00	2199
2025-03-26	SKIN	1.34	0.16	999.99	2223
2025-03-27	SKIN	1.355	0.21	999.99	2328
2025-03-28	SKIN	1.315	0.21	0.00	2334
2025-03-31	SKIN	1.35	0.21	0.00	2334
2025-04-01	SKIN	1.23	0.21	999.99	2334
2025-04-02	SKIN	1.48	0.22	1.25	2335
2025-04-03	SKIN	1.33	0.22	0.83	2335
2025-04-04	SKIN	1.19	0.22	0.18	2342
2025-04-07	SKIN	1.04	0.23	0.00	2344
2025-04-08	SKIN	1.045	0.22	999.99	2376
2025-04-09	SKIN	1.075	0.22	0.02	2377
2025-04-10	SKIN	1	0.22	0.02	2377
2025-04-11	SKIN	1.045	0.22	999.99	2388
2025-04-14	SKIN	0.9915	0.22	999.99	2387
2025-04-15	SKIN	0.9981	0.23	999.99	2403
2025-04-16	SKIN	0.86	0.23	4.00	2403
2025-04-17	SKIN	0.855	0.23	0.00	2401
2025-04-18	SKIN	0.8458	0.23	0.29	2401
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-21	SKIN	1.31	-238.1	-	-0.06
2025-03-24	SKIN	1.41	-238.1	-	-0.06
2025-03-25	SKIN	1.41	-238.1	-	-0.06
2025-03-26	SKIN	1.34	-238.1	-	-0.06
2025-03-27	SKIN	1.36	-238.1	-	-0.06
2025-03-28	SKIN	1.32	-238.1	-	-0.06
2025-03-31	SKIN	1.34	-238.1	-	-0.06
2025-04-01	SKIN	1.23	-238.1	-	-0.06
2025-04-02	SKIN	1.48	-238.1	-	-0.06
2025-04-03	SKIN	1.33	-238.1	-	-0.06
2025-04-04	SKIN	1.20	-238.1	-	-0.06
2025-04-07	SKIN	1.04	-238.1	-	-0.06
2025-04-08	SKIN	1.04	-238.1	-	-0.06
2025-04-09	SKIN	1.08	-238.1	-	-0.06
2025-04-10	SKIN	1.00	-238.1	-	-0.06
2025-04-11	SKIN	1.05	-238.1	-	-0.06
2025-04-14	SKIN	1.00	-238.1	-	-0.06
2025-04-15	SKIN	1.00	-238.1	-	-0.06
2025-04-16	SKIN	0.86	-238.1	-	-0.06
2025-04-17	SKIN	0.85	-238.1	-	-0.06
2025-04-18	SKIN	0.85	-238.1	-	-0.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-21	SKIN	-0.03	2.47	11.49
2025-03-24	SKIN	-0.03	2.49	11.49
2025-03-25	SKIN	-0.03	2.49	11.49
2025-03-26	SKIN	-0.03	2.49	11.71
2025-03-27	SKIN	-0.03	2.49	11.71
2025-03-28	SKIN	-0.03	2.49	11.71
2025-03-31	SKIN	-0.03	2.47	11.71
2025-04-01	SKIN	-0.03	2.47	11.71
2025-04-02	SKIN	-0.03	2.47	11.71
2025-04-03	SKIN	-0.03	2.47	11.71
2025-04-04	SKIN	-0.03	2.47	11.71
2025-04-07	SKIN	-0.03	2.47	11.71
2025-04-08	SKIN	-0.03	2.47	11.71
2025-04-09	SKIN	-0.03	2.47	11.71
2025-04-10	SKIN	-0.03	2.47	11.40
2025-04-11	SKIN	-0.03	2.47	11.40
2025-04-14	SKIN	-0.03	2.47	11.40
2025-04-15	SKIN	-0.03	2.47	11.40
2025-04-16	SKIN	-0.03	2.47	11.40
2025-04-17	SKIN	-0.03	2.47	11.40
2025-04-18	SKIN	-0.03	2.47	11.38
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.08

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

Insider Transactions

-0.03

Institutional Transactions

2.47

Beta

1.02

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

0.98

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.2

Max Drawdown 5-Year %

Target Price

1.57

P/E

Forward P/E

PEG

P/S

0.32

P/B

2.04

P/Free Cash Flow

6.89

EPS

-0.43

Average EPS Est. Cur. Y

-0.06

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.7

Relative Volume

0.89

Return on Equity vs Sector %

-81.1

Return on Equity vs Industry %

-83.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

The Beauty Health Company

Sector: Consumer Defensive

Industry: Household & Personal Products

Employees: 769

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

stock quote shares SKIN – The Beauty Health Company Stock Price stock today

news today SKIN – The Beauty Health Company stock forecast ,stock prediction 2023 2024 2025

marketwatch SKIN – The Beauty Health Company yahoo finance google finance

stock history SKIN – The Beauty Health Company invest stock market

stock prices SKIN premarket after hours

ticker SKIN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SKIN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y